PHIO

Phio Pharmaceuticals Corp. PHIO

PHIO
Phio Pharmaceuticals Corp. RNAZ
TransCode Therapeutics, Inc. KPRX
Kiora Pharmaceuticals, Inc. INAB
IN8bio, Inc. BCDA
BioCardia, Inc. APRE
Aprea Therapeutics, Inc. MRKR
Marker Therapeutics, Inc. GLTO
Galecto, Inc. CELZ
Creative Medical Technology Holdings, Inc. ACXP
Acurx Pharmaceuticals, Inc.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode PHIO RNAZ KPRX INAB BCDA APRE MRKR GLTO CELZ ACXP
6M -52.86 % 4.62 % -32.50 % -44.50 % -38.94 % -43.29 % -11.72 % 706.23 % -14.57 % -69.73 %
YTD -43.68 % -88.55 % -39.66 % -85.61 % -43.81 % -73.95 % -59.75 % 376.67 % -8.66 % -80.18 %
1Y -38.51 % -89.52 % -33.33 % -83.22 % -30.98 % -71.21 % -65.68 % 483.05 % 5.50 % -78.05 %
3Y -97.46 % -100.00 % -92.26 % -97.67 % -98.31 % -86.32 % -55.86 % -15.09 % -45.34 % -95.58 %
5Y -99.61 % -100.00 % -99.88 % -99.60 % -99.25 % -99.82 % -91.85 % -92.32 % -84.37 % -97.89 %
10Y -100.00 % -100.00 % -99.98 % -99.60 % -99.67 % -99.77 % -98.25 % -92.75 % -99.97 % -97.89 %
Depuis le début -99.66 % -100.00 % -99.99 % -99.60 % -100.00 % -99.77 % -100.00 % -92.75 % -99.97 % -97.89 %

Dividende